Clinical outcomes in patients with multiple sclerosis (MS) are adversely affected by increased blood levels of low-density lipoprotein (LDL), total cholesterol, and triglycerides, researchers said here on October 14 at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
Dyslipidaemia independently predicts an increased risk for cardiovascular complications via mechanisms related to activation of inflammatory processes at the vascular endothelial level, said lead study author Bianca Weinstock-Guttman, MD, Jacobs Neurological Institute, Buffalo, New York.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1092